NVEC.NASDAQNve CORP /NEW/

DEF: NVE Corporation Schedules 2025 Annual Meeting, Details Board Nominees and Executive Compensation Amidst Industry Downturn

Sentiment:

Definitive Proxy Statement


NVE Corporation has announced its 2025 Annual Meeting of Shareholders, outlining proposals for director elections, executive compensation, and auditor ratification, while reporting a decrease in fiscal 2025 income from operations despite sequential revenue growth.

Worse than expectedIncome from operations decreased to $16.0 million in fiscal 2025 from $18.5 million in fiscal 2024 and $25.6 million in fiscal 2023.Net income decreased to $15.1 million in fiscal 2025 from $17.1 million in fiscal 2024 and $22.7 million in fiscal 2023.Diluted earnings per share decreased to $3.12 in fiscal 2025 from $3.54 in fiscal 2024 and $4.69 in fiscal 2023.The decrease in performance-based compensation for executive officers was directly attributed to a decrease in Company operating income.

Summary

  • NVE Corporation will hold its 2025 Annual Meeting of Shareholders on Thursday, August 7, 2025, at 3:30 p.m. Central Daylight Time at its offices in Eden Prairie, Minnesota.
  • Shareholders will vote on the election of five incumbent directors, an advisory resolution regarding named executive officer compensation, and the ratification of Boulay PLLP as the independent registered public accounting firm for fiscal year 2026.
  • As of June 13, 2025, there were 4,837,166 shares of NVE's common stock outstanding.
  • For the fiscal year ended March 31, 2025, NVE reported income from operations of $16.0 million, net income of $15.1 million, and diluted earnings per share of $3.12.
  • The company maintained a gross profit of 84% of revenue and income from operations at 62% of revenue in fiscal 2025.
  • NVE experienced a 44% sequential revenue growth for the quarter ended March 31, 2025, indicating improving industry conditions.
  • The total shareholder return for the three years ended March 31, 2025, was 39%, comprising 17% stock appreciation and 22% from dividends.
  • CEO Daniel A. Baker's total compensation increased 1% in fiscal 2025 to $586,515, primarily due to a 4% salary increase and higher option award value, partially offset by a 14% decrease in performance-based compensation due to lower operating income.
  • The Board of Directors unanimously recommends a vote FOR all director nominees, FOR the advisory approval of named executive officer compensation, and FOR the ratification of Boulay PLLP.

Sentiment

Score: 6

Explanation: While fiscal year 2025 financial performance showed a decline in key metrics (revenue, operating income, net income, EPS) compared to prior years, attributed to an 'industry downturn,' the company reported strong 44% sequential revenue growth in the most recent quarter, suggesting a potential recovery. Corporate governance practices appear robust, and the three-year total shareholder return is positive. The annual financial decline is a negative, but the recent sequential growth and strong governance mitigate a lower score.

Positives

  • NVE Corporation reported strong 44% sequential revenue growth for the quarter ended March 31, 2025, signaling improving industry conditions.
  • The company maintained high profitability margins in fiscal 2025, with gross profit at 84% of revenue and income from operations at 62% of revenue.
  • NVE delivered a robust total shareholder return of 39% over the three years ended March 31, 2025, including 17% from stock appreciation and 22% from dividends.
  • The company demonstrates strong corporate governance with separate CEO and independent Chairman roles since 2001, and a board composed primarily of independent directors.
  • Comprehensive policies are in place for human rights, whistleblower protection, and insider trading, aligning with ethical business practices.
  • The Board actively oversees various risks, including financial, operational, cybersecurity, and climate policy risks, and conducts annual self-evaluations.
  • NVE has not experienced any cybersecurity incidents in the last three years, indicating effective risk management in this area.
  • The executive compensation program is designed to align with shareholder interests, linking CEO pay to growth and profitability, and the CEO holds significant company stock (9 times his fiscal 2025 salary).
  • The company maintains a low stock option burn rate and overhang, and avoids executive perks or 'golden parachutes', reflecting a shareholder-friendly compensation approach.
  • Shareholders showed strong support for executive compensation at the 2024 Annual Meeting, with 97% of votes in favor.

Negatives

  • NVE experienced a decrease in revenue in fiscal 2025, attributed to an industry downturn.
  • Income from operations declined to $16.0 million in fiscal 2025, down from $18.5 million in fiscal 2024 and $25.6 million in fiscal 2023.
  • Net income decreased to $15.1 million in fiscal 2025, compared to $17.1 million in fiscal 2024 and $22.7 million in fiscal 2023.
  • Diluted earnings per share fell to $3.12 in fiscal 2025, from $3.54 in fiscal 2024 and $4.69 in fiscal 2023.
  • Performance-based compensation for the CEO and Vice President of Advanced Technology decreased by 14% in fiscal 2025 due to the decline in Company operating income.
  • A stock option grant to CEO Daniel A. Baker on April 29, 2024, became 'underwater' immediately following the earnings release and remained so as of its vesting date, with a (2.1%) decrease in stock price.
  • The company does not utilize external compensation consultants or engage in peer-based compensation benchmarking, relying instead on internal expertise and general market surveys.

Risks

  • The company is susceptible to industry downturns, as evidenced by the decrease in fiscal 2025 revenue.
  • Cybersecurity risks are a concern, with the Board actively overseeing management's plans to mitigate them.
  • The effects and risks of climate change are identified as emerging risks that the Board oversees.
  • The company faces challenges in attracting, motivating, and retaining top talent in a competitive environment.
  • Operational and business risks are continuously assessed and mitigated by management under Board oversight.
  • Risks related to internal controls over financial reporting are considered by the Audit Committee.

Future Outlook

The document indicates improving industry conditions, as evidenced by 44% sequential revenue growth for the quarter ended March 31, 2025. The company's growth strategy may include corporate development, mergers, and acquisitions. The Board also annually reviews CEO succession planning and reassesses the risk environment, including identifying significant emerging risks.

Management Comments

  • "We cordially invite you to attend our 2025 Annual Meeting of Shareholders."
  • "Thank you for your support of NVE."
  • "Our Board is not aware that any matter other than those described in this Proxy Statement will be presented for action at the 2025 Annual Meeting."
  • "We were pleased with our fiscal 2025 performance despite a decrease in revenue in the face of an industry downturn."
  • "Our Compensation Committee believes our NEO pay is similar or less than most comparable public companies."
  • "We believe this is evidence that our compensation programs are consistent with our shareholders interests." (referring to 97% say-on-pay approval in 2024)
  • "We believe income from operations is an important metric because it captures revenue as well as costs and expenses."

Industry Context

The document highlights an 'industry downturn' that negatively impacted NVE's fiscal 2025 revenue, although it notes a significant 44% sequential revenue growth in the most recent quarter, suggesting a potential recovery. NVE operates within the electronics and semiconductor industries, with a notable presence in the medical device sensor market. The company's board composition reflects a strategic emphasis on experience in these sectors, acknowledging the unique challenges faced by smaller semiconductor companies. Furthermore, NVE's adherence to the TCFD framework for climate policy reporting aligns with broader industry trends towards increased environmental, social, and governance (ESG) transparency, even for companies not classified as major greenhouse gas emitters.

Comparison to Industry Standards

  • The Compensation Committee believes NVE's Named Executive Officer (NEO) pay is 'similar or less than most comparable public companies,' though specific comparable companies or benchmarks are not provided.
  • The company's 'low stock option burn rate and overhang' is generally considered a positive practice compared to industry norms that might lead to excessive shareholder dilution.
  • NVE's adoption of a clawback policy in compliance with NASDAQ listing standards and its prohibition on pledging, hedging, and other derivative transactions for directors and NEOs align with evolving best practices in corporate governance and risk management.
  • The company's climate policy report, aligned with the Task Force on Climate-Related Financial Disclosures (TCFD) framework, demonstrates adherence to emerging industry standards for climate-related financial disclosures, even as a non-significant GHG emitter.
  • No specific comparable companies, projects, or detailed numerical results from competitors are listed for direct comparison within the document.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Principal Financial OfficerNADaniel NelsonMay 8, 2023Promotion from Senior Accountant, having joined NVE in 2022.
DirectorNAKelly WeiMay 2024New appointment to the Board of Directors.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Policy ChangeThe Compensation Committee adopted a new practice of granting fiscal year-end incentive stock options two business days after the release of fiscal year results, moving it outside the material nonpublic information window defined in Item 402(x)(2).Beginning this fiscal year (FY2025)Aims to enhance transparency and avoid perceptions of timing equity awards based on material nonpublic information, aligning with new SEC rules.

Stakeholder Impact

  • **Shareholders**: Directly impacted by the proposals to be voted on (director elections, executive compensation, auditor ratification). Benefit from the company's focus on maximizing shareholder value, strong corporate governance, and positive total shareholder return over three years (39%). Affected by the decrease in net income and EPS in fiscal 2025, but also by sequential revenue growth.
  • **Employees**: Benefit from the company's commitment to human rights, whistleblower protection, employee health and safety, and participation in 401(k) and other benefit programs under the same terms as NEOs. Subject to non-competition, confidentiality, and invention assignment provisions.
  • **Management/Executive Officers**: Compensation is tied to company performance (income from operations), with a focus on growth and profitability. Subject to clawback policies and prohibitions on pledging/hedging securities.
  • **Auditors (Boulay PLLP)**: Their engagement for fiscal 2026 is subject to shareholder ratification.
  • **Customers**: Indirectly impacted by the company's strategic focus on electronics, semiconductor, and medical device industries, and its sales strategy.
  • **Suppliers**: Subject to the company's Human Rights Policy, which prohibits child labor and human trafficking in the supply chain.

Next Steps

  • Hold the 2025 Annual Meeting of Shareholders on August 7, 2025, for shareholder votes on director elections, executive compensation, and auditor ratification.
  • The Audit Committee will reconsider Boulay PLLP's engagement if shareholders do not ratify their selection.
  • The Compensation Committee will take the advisory vote on Named Executive Officer (NEO) compensation into account for future compensation decisions.
  • NVE plans to file its insider trading policies and procedures with its next Annual Report on Form 10-K.
  • The Compensation Committee has adopted a new practice, effective this fiscal year, of granting fiscal year-end incentive stock options two business days after the release of fiscal year results, moving it outside the material nonpublic information window.

Key Dates

DateDescription
1993Terrence W. Glarner became President of West Concord Ventures, Inc.
1993Daniel A. Baker became President and CEO of Printware, Inc.
1995Patricia M. Hollister joined FSI International Inc.
1996Printware, Inc. became publicly traded.
1998Patricia M. Hollister served as chief financial officer of FSI International Inc.
1999Terrence W. Glarner became a director of NVE.
2000Daniel A. Baker's tenure as Printware director ended.
January 2001Terrence W. Glarner became Chairman of the Board.
2001Daniel A. Baker became a director and NVE's President and CEO.
2001NVE adopted formal policies and procedures covering insider trading and insider dealing.
2003Peter G. Eames joined NVE.
2004Patricia M. Hollister became a director of NVE.
2004James W. Bracke became President of Boulder Creek Consulting, LLC.
2004Kelly Wei started her career as a senior research scientist at Boston Scientific Corporation.
2007Kelly Wei held various scientific, engineering, management, and senior management positions at Medtronic plc.
May 15, 2008Amended and Restated Audit Committee Charter adopted by the Board of Directors of NVE Corporation.
2009James W. Bracke became a director of Autoscope Technologies Corporation.
2011Shareholders voted in favor of an advisory vote regarding NEO compensation at the Annual Meeting.
September 2011James W. Bracke became Chairman of the Image Sensing Systems Board.
2012FSI International Inc. was acquired by TEL.
2012NVE began holding annual say-on-pay votes.
April 2014James W. Bracke became Vice President of Oral Health at EPIEN Medical Inc.
June 2016James W. Bracke's tenure as Chairman of the Image Sensing Systems Board ended.
2016Patricia M. Hollister retired from TEL FSI, Inc.
2016Peter G. Eames became Vice President of Advanced Technology.
2017Shareholders voted in favor of an advisory vote regarding NEO compensation at the Annual Meeting.
September 2018James W. Bracke's tenure as Vice President of Oral Health at EPIEN Medical Inc. ended.
Fiscal 2020Boulay PLLP began auditing NVE's financial statements.
2021James W. Bracke became a director of NVE.
2021Kelly Wei became a member of the Board of Trustees of the Williams Syndrome Association.
August 2021Daniel Nelson worked at RMH Tax & Business Advisors.
July 2021Daniel Nelson's tenure as senior accountant at Intelligere ended.
September 2022Daniel Nelson joined NVE as Senior Accountant.
March 31, 2022Base date for Total Shareholder Return calculation ($100 investment).
2023Shareholders voted in favor of an advisory vote regarding NEO compensation at the Annual Meeting.
May 8, 2023Daniel Nelson was promoted to Principal Financial Officer.
December 3, 2024Schedule 13G filed by Royce & Associates, LP.
February 2024Kelly Wei became a member of the Board of Directors of Abova, Inc.
April 29, 2024Grant date for Daniel A. Baker's incentive stock option award.
May 1, 2024Fiscal 2024 results furnished with Current Report on Form 8-K and included in Annual Report on Form 10-K.
May 2024Kelly Wei became a director of NVE.
May 2, 2025Schedule 13F filed by BlackRock Inc.
May 6, 2025Schedule 13F filed by Royce & Associates, LP.
May 7, 2025Annual Report on Form 10-K for fiscal year ended March 31, 2025, and Current Report on Form 8-K filed with the SEC.
May 9, 2025Schedule 13F filed by Vanguard Group Inc.
May 13, 2025Deadline for shareholder proposals to be presented at the 2025 Annual Meeting without inclusion in proxy statement.
May 14, 2025Schedule 13F filed by Kayne Anderson Rudnick Investment Management, LLC.
June 13, 2025Record date for voting at the 2025 Annual Meeting; date for beneficial ownership and board skills/diversity matrix.
June 23, 2025Date Proxy Statement and accompanying form of Proxy were first mailed or made accessible to shareholders.
August 6, 2025Deadline for voting by mail or Internet before the Annual Meeting.
August 7, 2025Date of the 2025 Annual Meeting of Shareholders.
March 31, 2026End of fiscal year for which Boulay PLLP is selected as independent registered public accounting firm.

Recommendation

hold

Keywords

SEC Filing, Proxy Statement, Annual Meeting, Corporate Governance, Executive Compensation, Board of Directors, Financial Performance, Semiconductor Industry, Medical Device Industry, Risk Management, Shareholder Return, NVE Corporation, DEF 14A, Audit Committee, Compensation Committee, Nominating/Corporate Governance Committee, Stock Options, Earnings Per Share, Income from Operations, Net Income, Shareholder Vote, Public Company

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.